Follicum AB   Report issue

For profit Phase 2
Founded: Lund Sweden (2011)
Status: Acquired by Coegin Pharma AB (2022)

Organization Overview

First Clinical Trial
2016
NCT02793557
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Follicum AB

Active Ingredients

Drugs in Phase 2 Trials (1)

fol-005 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 2)

Hirsutism (Phase 2)

Hypertrichosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1